loading

Maze Therapeutics Inc 주식(MAZE)의 최신 뉴스

pulisher
Oct 21, 2025

Maze Therapeutics Inc. recovery potential after sell offPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Pattern recognition hints at Maze Therapeutics Inc. upsideWeekly Trade Review & Long-Term Safe Investment Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Does Maze Therapeutics Inc. qualify in momentum factor screeningNew Guidance & Verified Momentum Stock Watchlist - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Developing predictive dashboards with Maze Therapeutics Inc. dataJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Will Maze Therapeutics Inc. outperform the marketPortfolio Update Report & Verified Momentum Watchlists - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What is the fair value of Maze Therapeutics Inc. stock nowJuly 2025 Levels & Precise Buy Zone Identification - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Can Maze Therapeutics Inc. stock beat market expectations this quarterPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Why Maze Therapeutics Inc. is moving todayWeekly Profit Recap & Verified High Yield Trade Plans - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Can Maze Therapeutics Inc. stock deliver sustainable ROEJuly 2025 Action & Real-Time Stock Price Movement Reports - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Maze Therapeutics Inc. stock a top momentum playTrade Exit Summary & Community Consensus Stock Picks - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Maze Therapeutics Inc. stock rally after Fed decisionsQuarterly Market Review & Technical Entry and Exit Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

What drives Maze Therapeutics Inc stock priceDividend Growth Stocks & Analyze Your Portfolio Risk in Seconds - earlytimes.in

Oct 18, 2025
pulisher
Oct 18, 2025

Portfolio Update: Will Maze Therapeutics Inc. stock benefit from AI adoptionMarket Volume Report & Verified Momentum Watchlists - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Maze Therapeutics Inc. stock benefit from AI adoptionPortfolio Return Summary & Verified Chart Pattern Signals - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 11, 2025

ETFs Investing in Maze Therapeutics, Inc. Stocks - TradingView

Oct 11, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D)" Rating for Maze Therapeutics (NASDAQ:MAZE) - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Can a trend reversal in Maze Therapeutics Inc. lead to recovery2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

How to use a screener to detect Maze Therapeutics Inc. breakoutsWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Forecast to 2035 Featuring Amicus Therapeutics, Astellas, BioMarin, Maze Therapeutics, Oxyrane ParasailResearchAndMarkets.com - The AI Journal

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics (NASDAQ:MAZE) Reaches New 1-Year HighWhat's Next? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Herve Hoppenot as Board Chairman - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

What technical models suggest about Maze Therapeutics Inc.’s comeback2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as chairman of the board - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Hervé Hoppenot as Chairman - TipRanks

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as board chairman - Investing.com India

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as board chairman By Investing.com - Investing.com Australia

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Detecting price anomalies in Maze Therapeutics Inc. with AI2025 Sector Review & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Predicting Maze Therapeutics Inc. trend using moving averages2025 Top Decliners & Verified Swing Trading Watchlist - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Maze Therapeutics (MAZE): Assessing Current Valuation Following a 78% Monthly Share Price Surge - Sahm

Oct 04, 2025
pulisher
Oct 04, 2025

Maze Therapeutics (MAZE): Assessing Valuation After 78% 30-Day Share Price Surge - Yahoo Finance

Oct 04, 2025
$37.23
price down icon 0.64%
$87.50
price up icon 0.21%
$29.73
price down icon 1.28%
$105.48
price down icon 1.16%
$160.22
price down icon 3.03%
biotechnology ONC
$311.71
price down icon 1.26%
자본화:     |  볼륨(24시간):